{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:05:56Z","timestamp":1771682756132,"version":"3.50.1"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jns.2026.125768","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:15:17Z","timestamp":1769213717000},"page":"125768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Letter to the editor: Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study"],"prefix":"10.1016","volume":"482","author":[{"given":"Yao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.125768_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.125671","article-title":"Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study","volume":"479","author":"Di Stefano","year":"2025","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125768_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114636","article-title":"Potential impact of underlying diseases influencing ADME in nonclinical safety assessment","volume":"188","author":"Cho","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jns.2026.125768_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119484","article-title":"Gastrointestinal adverse events associated with SNRIs: a FAERS-based pharmacovigilance study","volume":"387","author":"Lin","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"6 Suppl","key":"10.1016\/j.jns.2026.125768_bb0020","first-page":"S92","article-title":"Immunoglobulin use in immune deficiency and autoimmune disease states","volume":"25","author":"Perez","year":"2019","journal-title":"Am. J. Manag. Care"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:30:48Z","timestamp":1771680648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":4,"alternative-id":["S0022510X26000493"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125768","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter to the editor: Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125769","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125768"}}